Table: Zeria Pharm -2025/26 group results

Zeria Pharmaceutical

08/05/2026 08:01

May 8 (Reuters)- 
          Zeria Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales           89.16           87.31          95.00         45.00    
               (+2.1 pct)      (+15.3 pct)    (+6.6 pct)    (+12.6 pct) 
  Operating       12.37           12.20          13.00          6.00    
               (+1.4 pct)      (+26.8 pct)    (+5.1 pct)    (+64.8 pct) 
  Recurring       11.04           12.84          13.00          6.00    
               (-14.0 pct)     (+50.8 pct)    (+17.7 pct)  (+125.9 pct) 
  Net
  Net              8.45            9.94          10.00          4.00    
               (-14.9 pct)     (+28.5 pct)    (+18.3 pct)  (+130.2 pct) 
  EPS          191.80 yen      225.42 yen     226.86 yen     90.75 yen  
  Ann Div       49.00 yen       47.00 yen      50.00 yen                
  -Q2 Div       24.00 yen       23.00 yen      25.00 yen                
  -Q4 Div       25.00 yen       24.00 yen      25.00 yen                
  
  NOTE - Zeria Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T